Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.

 

3. Integra LifeSciences to pay $60M for Medtronic ENT instruments

Integra LifeSciences said today that it agreed to pay $60 million to acquire Medtronic’s MicroFrance and Xomed manual ENT and laparoscopy instrument lines.

The deal includes a plant in St. Aubin le Monial, France, where the MicroFrance business makes the Xomed line. Integra said it will end up with roughly 4,000 MicroFrance and Xomed manual ENT and laparoscopic surgical instruments once the deal closes, expected during the 4th quarter. Read more

2. Insulet CEO DeSisto steps down

Insulet said today that longtime CEO Duane DeSisto is stepping down after a 13-year run at the insulin management company.

Former Cytyc chairman, president & CEO Patrick Sullivan was named to succeed DeSisto, according to a press release. Billerica, Mass.-based Insulet makes the OmniPod tubeless insulin management system. Read more

1. Paulsen takes another run at medical device tax repeal

The U.S. House of Representatives is slated to take up a package of already-passed jobs bills this week, including a provision sponsored by Rep. Erik Paulsen that would repeal the medical device tax.

MassDevice.com spoke with Paulsen about the upcoming vote and why now might be the most propitious moment for repealing the tax, a 2.3% excise levy on U.S. sales of prescribed medical devices that was enacted along with the Affordable Care Act in 2010. Read more